Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery

PHASE3TerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Heart; Dysfunction Postoperative, Cardiac Surgery
Interventions
DRUG

Ranolazine

Ranolazine 1000mg (2-500mg tablets) twice daily. Starting 2 days prior to surgery, morning of surgery and up to 14 days post operative depending when the breathing tube is removed from the patient post operative. If intolerant to the study drug due to adverse effects or the patient is started on diltiazem or verapamil post operative then the dose will be reduced to 500mg (1-500mg tablet) twice daily

DRUG

Placebo

Placebo 1000mg (2-500mg tablets) twice daily. Starting 2 days prior to surgery, morning of surgery and up to 14 days post operative depending when the breathing tube is removed from the patient post operative. If intolerant to the study drug due to adverse effects or the patient is started on diltiazem or verapamil post operative then the dose will be reduced to 500mg (1-500mg tablet) twice daily

Trial Locations (2)

48073

William Beaumont Hospital, Royal Oak

48085-1198

William Beaumont Hospital, Troy

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Beaumont Foundation of America

OTHER

collaborator

Gilead Sciences

INDUSTRY

lead

William Beaumont Hospitals

OTHER